Skip to main content

Table 4 Rate of MCIC Achievement

From: Estimation of minimal clinically important change of the Japanese version of EQ-5D in patients with chronic noncancer pain: a retrospective research using real-world data

 

PGI Effective

NRS ≤ −2

EQ-5D  0.10

Overall

614 (86.5)

487 (68.6)

405 (57.0)

Major the causal disease of pain (multiple allowed)

   

 Osteoarthritis

168 (92.3)

130 (71.4)

113 (62.1)

 Lumbago

253 (88.8)

214 (75.1)

177 (62.1)

 Rheumatoid arthritis

21 (72.4)

18 (62.1)

13 (44.8)

 Neck, shoulder and arm syndrome

38 (86.4)

32 (72.7)

22 (50.0)

 Postherpetic neuralgia

46 (85.2)

39 (72.2)

30 (55.6)

 Periarthritis scapulohumeralis

39 (84.8)

33 (71.7)

21 (45.7)

 Spinal stenosis

47 (77.0)

37 (60.7)

26 (42.6)

 Disk herniation

27 (90.0)

18 (60.0)

17 (56.7)

 Others

196 (84.1)

142 (60.9)

112 (48.1)

  1. EQ-5D denotes EuroQol-5D, MCIC minimal clinically important change, NRS numeric rating scale, PGI physician’s global impression